瑞銀:升中燃(0384.HK)目標價至40港元 評級“買入”
瑞銀報告指出,參與中國燃氣(00384.HK)在新加坡舉行的路演後,認為市場對前景過分擔憂,加上其股價較業績公佈前的高點已回調約12%,維持“買入”評級。
報告指,投資者對中燃股東韓國SK集團拋售股票感擔憂,該行表示對於SK集團是否會繼續出售沒有任何看法,但認為SK集團早前套現價30元將是股價支撐位,又指出SK集團將自己定位為中國燃氣的戰略投資者,股權低於10%將令其失去在董事會的席位(目前11.71%)。
瑞銀指,中燃目前股價為2021年預測市盈率的13倍,計及對2019至2022財年盈利複合增長率22%的預測,認為現價具吸引力,因此將目標價由37.5港元提升至40港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.